Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Viking Aktie: Phase-3-Pläne

TorstenPinkert 
0 0 12.02.26
Viking Aktie: Phase-3-Pläne
 

Viking Therapeutics will sein orales Adipositas-Medikament VK2735 noch in diesem Jahr in die Phase…

Der Beitrag Viking Aktie: Phase-3-Pläne erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Viking Therapeutics Inc Stock

€25.59
-0.720%
Viking Therapeutics Inc shows a slight decrease today, losing -€0.185 (-0.720%) compared to yesterday.
Our community is currently high on Viking Therapeutics Inc with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 25 € is below the current price of 25.59 € for Viking Therapeutics Inc, so the potential is actually -2.31%.
Show more
Like: 0
Analystenstimmen
Share

Comments

Not a member yet? Sign up for free!